Related Experiment Video

Updated: Oct 19, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

The health care costs of heart failure in Sweden

T Rydén-Bergsten1, F Andersson

  • 1Department of Health Economics, AstraZeneca R&D, Mölndal, Sweden. tina.ryden-bergsten@hassle.se.astra.com

Journal of Internal Medicine
|September 4, 1999
PubMed

Insights

Heart failure treatment in Sweden costs SEK 2000-2600 million annually, representing nearly 2% of the national health care budget. Institutional care accounts for the majority of these significant heart failure treatment expenses.

Area of Science:

  • Health Economics
  • Cardiology
  • Public Health Policy

Background:

  • Heart failure is a prevalent and severe medical condition.
  • It necessitates substantial allocation of healthcare resources.

Purpose of the Study:

  • To quantify the total economic burden of heart failure treatment in Sweden.
  • To provide data for resource allocation and health policy development.

Main Methods:

  • A prevalence-based cost-of-illness methodology was employed.
  • Data sources included official Swedish statistics and clinical studies.
  • Costs encompassed institutional care, outpatient services, surgery, and pharmaceuticals.

Main Results:

  • Total annual heart failure treatment costs were estimated at SEK 2000-2600 million (1996 prices).
  • This represents approximately 2% of the total Swedish healthcare expenditure.
  • Institutional care constituted the largest cost component, ranging from SEK 1300-1900 million (65-75% of total costs).

Conclusions:

  • Heart failure imposes a significant financial burden on the Swedish healthcare system.
  • Prioritizing management programs to reduce reliance on costly institutional care is recommended.
  • Such programs should aim to maintain or improve patient quality of life, morbidity, and mortality outcomes.
Abstract

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...